Contract Services Contract Manufacturing

WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site

The PAI focused on the drug product manufacturing of an innovative drug for one of WuXi STA’s partners. During a 5-day remote inspection from Novembe...

 March 04, 2022 | News

Vetter’s extraordinary performance sweeps the board at the 2022 CMO Leadership Awards

Vetter’s high-level performance further substantiates its dedicated performance in customer-critical services Results affirm the approach, vision,...

 March 03, 2022 | News

Paras Biopharmaceuticals to expand global outreach of its ‘Biosimilar Development & Partnership’

Bioseet, based in Munich, Germany, is an enterprise encompassing a virtual marketplace and teamspace for Biosimilar and other generic assets to facilitate ...

 March 03, 2022 | News

Why are Regulations & Guidelines necessary for Drug Development & Manufacturing?

What Led To Drug Regulation? To make sure that a drug product is safe for consumption, it is imperative that the process of drug development and manufactu...

 March 01, 2022 | Opinion

Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYS...

 February 25, 2022 | News

Catalent Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China

The facility will be expanded by approximately 30,000 square feet (approximately 2,800 square meters), which will double the clinical storage capacity...

 February 16, 2022 | News

WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories

For the 2022 CMO Leadership Awards, Life Science Leader Magazine teamed up with Industry Standard Research (ISR) to conduct the Contract Manufacturing Qual...

 February 11, 2022 | News

Merck to Strengthen CDMO Offering and Accelerate Future Growth

New operating model to accelerate profitable growth strategy Newly formed Life Science Services business unit to offer fully integrated CDMO and Contrac...

 February 09, 2022 | News

Samsung Biologics receives 2022 CMO Leadership Award in all six categories

Now in its 11th year, the CMO Leadership Awards offer accurate and reliable customer feedback to provide support in choosing a reputable partner for develo...

 February 08, 2022 | News

National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development

The project initialized by National Cancer Center Research Institute. Under the agreement, National Cancer Center and GenScript Biotech will collaborate on...

 February 07, 2022 | News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

Dr. Michael Quirmbach, Chief Executive Officer & President of CordenPharma said, "We welcome the three sites and their employees as new members to...

 February 02, 2022 | News

Biogen to acquire full ownership of Samsung Bioepis

Agreement with Biogen to buyout Biogen's (50% -1 share) stake in Samsung Bioepis Joint Venture for up to USD $2.3 billion Transaction projected to ...

 January 28, 2022 | News

GenScript ProBio initiates a CDMO Contract For Next-Generation CD47 Antibody with InnoBation Bio

InnoBation Bio, led by Seung-gu Kim (CEO), is a biopharmaceutical company specializing in the development of biomarkers, Chimeric Antigen Receptor (CAR) T ...

 January 26, 2022 | News

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

Q4'21 revenue of KRW 444.3 billion increased 18% compared to Q4'20. Q4'21 operating profit of KRW 128.8 billion increased 39% compar...

 January 25, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close